AMGN - AMGEN INC
IEX Last Trade
261.22
-0.290 -0.111%
Share volume: 66,235
Last Updated: Fri 10 Jan 2025 08:29:53 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$261.51
-0.29
-0.11%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-02 | 2023-08-03 | 2023-10-31 | 2024-10-30 | 2024-05-02 | 2024-08-06 | 2024-10-30 | |
| Assets | ||||||||
| Total Assets | 88.720 B | 90.269 B | 90.534 B | 97.154 B | 92.980 B | 90.907 B | 90.883 B | |
| Current Assets | 44.703 B | 47.380 B | 48.477 B | 30.332 B | 28.029 B | 27.206 B | 26.766 B | |
| Inventories | 5.011 B | 4.978 B | 5.026 B | 9.518 B | 8.724 B | 7.995 B | 7.362 B | |
| Other Current Assets | 2.395 B | 2.324 B | 2.565 B | 2.602 B | 2.821 B | 2.976 B | 3.076 B | |
| Short Term Investments | 1.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 31.560 B | 34.248 B | 34.741 B | 10.944 B | 9.708 B | 9.301 B | 9.011 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.460 B | 5.532 B | 5.563 B | 5.941 B | 6.002 B | 6.097 B | 6.156 B | |
| Other Assets | 38.557 B | 37.357 B | 36.494 B | 60.881 B | 58.949 B | 57.604 B | 57.961 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 88.720 B | 90.269 B | 90.534 B | 97.154 B | 92.980 B | 90.907 B | 90.883 B | |
| Total liabilities | 83.372 B | 83.488 B | 82.878 B | 90.922 B | 87.958 B | 84.982 B | 83.356 B | |
| Total current liabilities | 14.215 B | 17.097 B | 16.954 B | 18.392 B | 19.714 B | 21.517 B | 20.312 B | |
| Accounts Payable | 1.320 B | 1.212 B | 1.358 B | 1.590 B | 1.628 B | 2.267 B | 2.147 B | |
| Other liabilities | 2.532 B | 2.536 B | 2.305 B | 2.326 B | 2.357 B | 2.363 B | 2.199 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 60.761 B | 59.377 B | 59.040 B | 63.170 B | 60.061 B | 57.117 B | 56.854 B | |
| Other liabilities | 2.532 B | 2.536 B | 2.305 B | 2.326 B | 2.357 B | 2.363 B | 2.199 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.348 B | 6.781 B | 7.656 B | 6.232 B | 5.022 B | 5.925 B | 7.527 B | |
| Common stock | 32.535 B | 32.601 B | 32.753 B | 33.070 B | 33.082 B | 33.204 B | 33.393 B | |
| Retained earnings | -26.919 B | -25.540 B | -24.971 B | -26.549 B | -27.870 B | -27.124 B | -25.530 B |